Nutraplus India Ltd Quarterly Results
Q1 FY15-16 Results Summary
Revenue
The revenue stands at ₹15.28 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 16.68 per cent from ₹18.34 crore. This corresponds to a year-on-year *(YoY) decline of 12.49 per cent.
Operating Profit
Operating Profit stands at ₹2.76 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.32 per cent from ₹2.22 crore. This corresponds to a year-on-year *(YoY) growth of 9.52 per cent.
PBDT
PBDT stands at ₹2.27 crore, reflecting a quarter-on-quarter *(QoQ) increase of 33.53 per cent from ₹1.70 crore. This corresponds to a year-on-year *(YoY) growth of 24.04 per cent.
Profit Before Tax
Profit Before Tax stands at ₹1.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 53.23 per cent from ₹1.24 crore. This corresponds to a year-on-year *(YoY) growth of 45.04 per cent.
Net Profit
Net Profit stands at ₹1.51 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 53.68 per cent from ₹3.26 crore. This represents a 46.60 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Nutraplus India Ltd Earnings
- YOY
- QOQ
Nutraplus India Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Nutraplus India Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Nutraplus India Ltd Financial Reports
Nutraplus India Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Unjha Formul. | 3.47% | 5.15% | -4.53% | -5.44% | -22.15% | -13.04% |
| Hind.Bio Science | 1.51% | -0.91% | -5.21% | 9.13% | 33.69% | -2.24% |
| Kobo Biotech | 4.91% | 20.85% | 20.00% | 36.80% | 27.61% | 22.14% |
| Decipher Labs | -2.50% | -1.54% | -10.57% | -6.40% | -32.17% | -41.84% |
| Vivanza Biosci. | 0.00% | -3.80% | -13.66% | -14.90% | -26.25% | -25.32% |
| Brawn Biotech | -2.04% | -6.81% | -7.87% | -6.81% | -2.85% | 10.18% |
| Colinz Labs | 5.00% | 4.55% | 2.67% | 2.44% | 14.41% | -23.00% |
Company Info
Company Information
Chairman & Managing Director : Mukesh Naik
Independent Non Exe. Director : Nitin Desai
Independent Non Exe. Director : Vinod Laxman Parab